Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?

被引:31
作者
Buc, E. [1 ]
Couvelard, A. [2 ]
Kwiatkowski, F. [3 ]
Dokmak, S. [1 ]
Ruszniewski, P. [4 ]
Hammel, P. [4 ]
Belghiti, J. [1 ]
Sauvanet, A. [1 ]
机构
[1] Hop Beaujon, AP HP, Pole Malad Appareil Digestif, Dept Hepatopancreato Biliary Surg, Clichy, France
[2] Hop Beaujon, AP HP, Dept Pathol, Clichy, France
[3] Ctr Jean Perrin, Dept Biostat, Clermont Ferrand, France
[4] Hop Beaujon, AP HP, Pole Malad Appareil Digestif, Dept Gastroenterol, Clichy, France
来源
EJSO | 2014年 / 40卷 / 11期
关键词
Pancreatic cancer; Lymph node; Prognosis; LONG-TERM SURVIVAL; EXTENDED LYMPHADENECTOMY; DUCTAL ADENOCARCINOMA; PERINEURAL INVASION; CANCER; PANCREATICODUODENECTOMY; INVOLVEMENT; GEMCITABINE; IMPACT; RATIO;
D O I
10.1016/j.ejso.2014.04.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lymph node (LN) invasion in pancreatic ductal adenocarcinoma (PDAC) is the most important prognostic factor after surgical resection. The mechanisms of LN invasion include lymphatic spreading and/or direct extension from the main tumor. However, few studies have assessed the impact of these different patterns of invasion on prognosis. Patients and methods: Pathologic reports of pancreatic resections for PDAC from 1997 to 2007 were retrospectively analyzed. The mode of LN invasion was defined as follows: standard lymphatic metastases (S), contiguous from the main tumor (C) and standard with extracapsular invasion (El). Clinical outcomes were compared according to the mode of invasion and the number of invaded LN. Results: 306 patients were reviewed. Median age at resection was 61 years (range, 34-81). Eighty seven patients were N-(28.9%) and 214 were N+ (71.1%). Of the N+ patients, 195 (91.1%) were S+, 35 (16.3%) were C+, and 24 (12.3% of the S+ patients) were EI+. Median survival in N+ patients was lower than in N patients (29 vs. 57 months, p <0.001). In patients without standard involvement, C+ patients (n = 19) had worse survival than C patients (n = 47) (34 vs. 57 months, p = 0.037). In S+ patients, C status was correlated with prognosis when the number of LN S+ was <2 (p = 0.07). El status had no influence on prognosis. On multivariate analysis, only perineural invasion (p = 0.02) and LN ratio (p = 0.042) were independent prognostic factors. Conclusion: Direct invasion of LN by the tumor is predictive of reduced survival, but has little impact compared to standard LN involvement and perineural invasion. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1578 / 1585
页数:8
相关论文
共 31 条
[11]   Surgical treatment of pancreatic adenocarcinoma: actual survival and prognostic factors in 343 patients [J].
Kuhlmann, KFCD ;
de Castro, SMM ;
Wesseling, JG ;
ten Kate, FJW ;
Offerhaus, GJA ;
Busch, ORC ;
van Gulik, TM ;
Obertop, H ;
Gouma, DJ .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (04) :549-558
[12]  
Kwiatkowski F, 2000, B CANCER, V87, P715
[13]   NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells [J].
Maehara, N ;
Matsumoto, K ;
Kuba, K ;
Mizumoto, K ;
Tanaka, M ;
Nakamura, T .
BRITISH JOURNAL OF CANCER, 2001, 84 (06) :864-873
[14]   Prognostic Significance of Lymph Node Metastases in Pancreatic Head Cancer Treated with Extended Lymphadenectomy: Not Just a Matter of Numbers [J].
Massucco, Paolo ;
Ribero, Dario ;
Sgotto, Enrico ;
Mellano, Alfredo ;
Muratore, Andrea ;
Capussotti, Lorenzo .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (12) :3323-3332
[15]   Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer [J].
Michalski, C. W. ;
Kleeff, J. ;
Wente, M. N. ;
Diener, M. K. ;
Buechler, M. W. ;
Friess, H. .
BRITISH JOURNAL OF SURGERY, 2007, 94 (03) :265-273
[16]   Number of Metastatic Lymph Nodes, but Not Lymph Node Ratio, Is an Independent Prognostic Factor after Resection of Pancreatic Carcinoma [J].
Murakami, Yoshiaki ;
Uemura, Kenichiro ;
Sudo, Takeshi ;
Hayashidani, Yasuo ;
Hashimoto, Yasushi ;
Nakashima, Akira ;
Yuasa, Yoshio ;
Kondo, Naru ;
Ohge, Hiroki ;
Sueda, Taijiro .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (02) :196-204
[17]   Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial [J].
Neoptolemos, John P. ;
Stocken, Deborah D. ;
Bassi, Claudio ;
Ghaneh, Paula ;
Cunningham, David ;
Goldstein, David ;
Padbury, Robert ;
Moore, Malcolm J. ;
Gallinger, Steven ;
Mariette, Christophe ;
Wente, Moritz N. ;
Izbicki, Jakob R. ;
Friess, Helmut ;
Lerch, Markus M. ;
Dervenis, Christos ;
Olah, Attila ;
Butturini, Giovanni ;
Doi, Ryuichiro ;
Lind, Pehr A. ;
Smith, David ;
Valle, Juan W. ;
Palmer, Daniel H. ;
Buckels, John A. ;
Thompson, Joyce ;
McKay, Colin J. ;
Rawcliffe, Charlotte L. ;
Buechler, Markus W. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (10) :1073-1081
[18]   Adjuvant therapy in pancreatic cancer - A critical appraisal [J].
Oettle, Helmut ;
Neuhaus, Peter .
DRUGS, 2007, 67 (16) :2293-2310
[19]  
Ozaki H, 1999, SURG TODAY, V29, P16
[20]   Pattern of Lymph Node Involvement and Prognosis in Pancreatic Adenocarcinoma: Direct Lymph Node Invasion Has Similar Survival to Node-Negative Disease [J].
Pai, Rish K. ;
Beck, Andrew H. ;
Mitchem, Jonathan ;
Linehan, David C. ;
Chang, Daniel T. ;
Norton, Jeffrey A. ;
Pai, Reetesh K. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (02) :228-234